| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.42 | 7e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 5e-08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.49 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |